Showing 1801-1810 of 2657 results for "".
- First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar Gel for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitishttps://modernod.com/news/first-patient-screened-in-mallinckrodt-phase-4-trial-of-h-p-acthar-gel-for-severe-noninfectious-intermediate-uveitis-posterior-uveitis-or-panuveitis/2479736/Mallinckrodt confirmed screening of the first patient in the company’s phase 4, multicenter, multiple-dose, open label study to assess the effects of H.P. Acthar Gel as
- PRAC Recommends Restrictions on Fluoroquinolone, Quinoloneshttps://modernod.com/news/prac-recommends-restrictions-on-fluoroquinolone-quinolones/2479807/The European Medicine Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of systemic and inhaled fluoroquinolone and quinolone antibiotics following a safety review, according to a Medscape
- New 10 Year Warranty for Haag-Streit Slit Lampshttps://modernod.com/news/new-10-year-warranty-for-haag-streit-slit-lamps/2479858/As of October 2018, Haag-Streit Diagnostics is introducing a 10 year limited warranty for its slit lamps. For more information on Haag-Streit’s slit lamps and the new warranty program, visit
- Quantel Medical Launches ABSolu Ultrasound Platformhttps://modernod.com/news/quantel-medical-launches-absolu-ultrasound-platform/2479884/Quantel Medical announced it will launch the ABSolu ultrasound platform at the ESCRS meeting in Vienna. Combining leading-edge technologies, the A/B/S/UBM ultrasound platform provides image quality with an exceptional
- Report: Takeda May Sell Shire Assets to Reduce Debt Following $62 Billion Purchasehttps://modernod.com/news/report-takeda-may-sell-shire-assets-to-reduce-debt-following-62-billion-purchase/2479892/According to people close to the situation, Takeda is considering selling Shire’s eye care business, including the dry eye disease treatment Xiidra (lifitegrast), once it completes the purchase of the company, Bloomberg
- Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement Focused on Novel Drug Delivery Technology in Ophthalmologyhttps://modernod.com/news/aerie-pharmaceuticals-and-dsm-biomedical-expand-collaboration-agreement-focused-on-novel-drug-delivery-technology-in-ophthalmology/2479966/Aerie Pharmaceuticals and DSM Biomedical reported that they have expanded their collaborative research, development, and license agreement. In July 2017, Aerie announced that it had entered into a research collaboration and license option agreement with DSM for purposes of evaluating the s
- Aussie Researchers Identify New Genetic Markers for Glaucomahttps://modernod.com/news/aussie-researchers-identify-new-genetic-markers-for-glaucoma/2479975/Australian researchers said they have identified 40 new genetic markers that increase a person’s risk of developing glaucoma, pointing to improvements in testing and predicting the risks of getting the eye disease, according to a
- CHOP Researchers Develop Highly Specific Predictive Screening Tool for Retinopathy in Premature Infantshttps://modernod.com/news/chop-researchers-develop-highly-specific-predictive-screening-tool-for-retinopathy-in-premature-infants/2480024/A multi-hospital collaboration led by researchers at Children’s Hospital of Philadelphia (CHOP) has found a simple method of determining which premature infants should be screened for retinopathy of prematurity (ROP). The recommendations have the potential t
- Retinal Thinning Tied to Cognitive Declinehttps://modernod.com/news/retinal-thinning-tied-to-cognitive-decline/2480058/Thinning of the eye’s retinal nerve fiber layer (RNFL) appears to be a strong predictor of cognitive decline, new research shows, according to a report in Medscape. Investigators found healthy individuals with RNFL thinning w
- RightEye Unveils EyeQ Trainer Personalized Computer-Based Vision Training Systemhttps://modernod.com/news/righteye-unveils-eyeq-trainer-personalized-computer-based-vision-training-system/2480076/RightEye unveiled its new EyeQ Trainer computer-based vision rehabilitation program at Optometry’s Meeting 2018 in Denver, Colorado (RightEye booth #611). EyeQ Trainer gives optometrists a tool their